← All drugs
Drug

Brolucizumab

45 flagged reaction(s) · 5,031 total co-reports · max PRR 352.1
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Vitreous Floaters 558 352.1 416.0 signal
2 Eye Inflammation 447 288.1 328.5 signal
3 Uveitis 361 159.0 176.5 signal
4 Visual Acuity Reduced 434 76.0 86.2 signal
5 Intraocular Pressure Increased 114 51.9 53.5 signal
6 Eye Haemorrhage 103 44.9 46.2 signal
7 Ocular Discomfort 78 41.9 42.8 signal
8 Blindness 244 34.9 37.3 signal
9 Eye Pain 319 33.6 36.8 signal
10 Ocular Hyperaemia 224 27.9 29.7 signal
11 Visual Impairment 569 26.9 31.7 signal
12 Blindness Unilateral 60 24.8 25.2 signal
13 Vision Blurred 533 22.7 26.4 signal
14 Photophobia 63 19.6 19.9 signal
15 Macular Degeneration 33 16.1 16.2 signal
16 Eye Discharge 25 14.2 14.3 signal
17 Glaucoma 47 14.2 14.3 signal
18 Retinal Detachment 22 13.9 14.0 signal
19 Lacrimation Increased 61 11.8 12.0 signal
20 Vasculitis 23 11.4 11.5 signal
21 Mydriasis 24 10.9 10.9 signal
22 Eye Pruritus 55 9.7 9.8 signal
23 Cataract 97 9.5 9.7 signal
24 Eye Infection 17 8.8 8.8 signal
25 Eye Irritation 84 8.7 8.9 signal
26 Eye Disorder 45 8.0 8.0 signal
27 Deformity 11 6.8 6.8 signal
28 Eye Swelling 43 6.7 6.8 signal
29 Injection Site Discomfort 11 6.2 6.2 signal
30 Dry Eye 49 5.9 5.9 signal
31 Conjunctivitis 15 4.7 4.7 signal
32 Hypoacusis 29 3.9 3.9 signal
33 Therapeutic Product Effect Decreased 28 3.7 3.7 signal
34 Cerebral Infarction 14 3.3 3.3 signal
35 Disease Progression 62 3.0 3.1 signal
36 Disease Recurrence 23 2.8 2.8 signal
37 Upper Limb Fracture 9 2.6 2.6 signal
38 Ischaemic Stroke 8 2.6 2.6 signal
39 Impaired Driving Ability 5 2.5 2.5 no signal
40 Anhedonia 11 2.4 2.4 signal
41 Eyelid Oedema 4 2.0 2.0 no signal
42 Product Storage Error 25 1.7 1.7 no signal
43 Injection Site Extravasation 3 1.4 1.4 no signal
44 Injection Site Irritation 3 1.4 1.4 no signal
45 Injection Site Pain 38 0.7 0.7 no signal